Curcumin effect on delayed onset muscle soreness

Comparison of the Effectiveness of Curcumin Supplement and Placebo in Improving Symptoms of Delayed Onset Muscle Soreness in Sedentary People

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191013045089N1

Enrollment

Registered

2020-06-27

Start date

2020-06-09

Completion date

Unknown

Last updated

2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delayed Onset Muscle Soreness. muscle

Interventions

Intervention 1: Intervention group: they will take 500 mg Curcumin supplement orally. They continue to take it for up to 7 days. Intervention 2: Control group: they will take placebo orally. They cont

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Sedentary people (people who do not participate in planned, structured physical activity at least 30 min at moderate intensity on at least 3 days per week during the last 3 months)

Exclusion criteria

Exclusion criteria: had participated in resistance training in the last six months history of muskuloskeletal injury in the last 2 months history of Delayed Onset Muscle Soreness (DOMS) in the last 3 months history of orthopedic, arthritis and inflammatory diseases regular consumption of medicine regular consumption of Non Steroidal Anti Inflammatory Drugs (NSAIDs) (at least 3 of 7 days) dietary supplements use in the previous 6 months intake of a curcumin supplement within the past 6 months history of Hypertension disease history of gallbladder disease

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: before intervention, after intervention, on 1st, 3rd, and 7th day. Method of measurement: Visual Analogue Scale (VAS).;Swelling. Timepoint: before intervention, after intervention, on 1st and 3rd day. Method of measurement: tape measure.;Muscle Strength. Timepoint: before intervention, after intervention, on 1st and 3rd day. Method of measurement: One-repetition maximum (1-RM).;Range of Motion. Timepoint: before intervention, after intervention, on 1st and 3rd day. Method of measurement: Goniometer.;Muscle Function. Timepoint: before intervention, after intervention, on 1st and 3rd day. Method of measurement: one-legged hop for distance test.	—

Measure

Time frame

Pain. Timepoint: before intervention, after intervention, on 1st, 3rd, and 7th day. Method of measurement: Visual Analogue Scale (VAS).;Swelling. Timepoint: before intervention, after intervention, on 1st and 3rd day. Method of measurement: tape measure.;Muscle Strength. Timepoint: before intervention, after intervention, on 1st and 3rd day. Method of measurement: One-repetition maximum (1-RM).;Range of Motion. Timepoint: before intervention, after intervention, on 1st and 3rd day. Method of measurement: Goniometer.;Muscle Function. Timepoint: before intervention, after intervention, on 1st and 3rd day. Method of measurement: one-legged hop for distance test.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBehnaz Mahdaviani

Shahid Beheshti University of Medical Sciences

behnazmahdaviani@gmail.com+98 21 2227 7713

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026